In October 2017, I brought an exclusive story of a mysterious sacking at the University of Edinburgh. The molecular biologist and epigenetics researcher Irina Stancheva was removed from her post as senior lecturer at the Scottish university, in total secret, all online traces of her employment rapidly deleted (even a promo video on Vimeo), her freshly obtained graduate school money redistributed to her faculty colleagues. The journal Nucleic Acid Research (NAR) soon after silently removed Stancheva as its Executive Editor. Still, I was able to gather some information, including leaked emails from Stancheva’s Head of Department David Gray (read here), but mysteriously no other media covered the story. Either heavily funded senior lecturers get sacked in Edinburgh on a weekly basis, or the university holds the newspapers in a vice grip in the Stancheva case. All my attempt at freedom of Information (FOI) were rejected by University of Edinburgh. There is a lot to hide: Stancheva is a third generation Edinburgh elite biologist: academic daughter of Professor of Human Genetics Richard Meehan and academic granddaughter of Meehan’s mentor, Professor of Genetics and Nobel Prize candidate Adrian Bird. Both Edinburg professors are co-authors on Stancheva’s papers flagged on PubPeer.
Now, after 8 months of silence, I received out of the blue an email from the same data protection officer who used to deny telling me the time of the day, with a list of Stancheva papers about to be retracted. The list follows below.
Continue reading “Edinburgh breaks silence to announce Stancheva retractions”
The German justice has spoken on trachea transplants again, in the appeal hearing at Kammergericht Berlin, and found the problem to lie with the journalists and press freedom. Good news first: I might have won the first injunction case against Philipp Jungebluth, or at least in large part, so I will probably get most of my money refunded there (Update 30.05.2018: the court tricked me and rejected my appeal on that injunction too. It remains valid to 1/3 just as before, see below). This only happened because the judges regarded how exactly Jungebluth left his job in Heidelberg being a minor enough issue (they did advice him to sue a Swedish newspaper for interviewing him about his sacking in Sweden (sic!)). This money I then will pay back to Paolo Macchiarini‘s acolyte and the court, and much, much more on top, because the three appeal court judges announced to uphold the second injunction in full. These are their oral arguments from yesterday summarised: Continue reading “No good news, instead a major disaster in appeal court re: Macchiarini affair”
My report from just a week ago, about the data irregularities in papers from Italian haematologist and cancer researcher Giorgio Zauli provoked a response of a legal threat, of both criminal and civil prosecution. Zauli is namely rector of the University of Ferrara, and he issued this threat in this official capacity, acting for his Italian university. I was already made aware of Zauli’s threats of suing me from a first-hand source, and my site was indeed accessed by Italian State prosecutor’s office the day after I published my article about Zauli’s flawed cytometry and other problematic data in research papers he mostly co-authored with Ferrara’s Head of Department, Paola Secchiero. This letter from Zauli below, which reached me today per certified mail, is the more bizarre due to the fact the university denied any knowledge of Zauli’s legal threats (see the update here).
In any case, here is the letter, on the headed paper of the University of Ferrara, which even paid the postage. Zauli and his university apparently assume that their research publications and public institutional profiles are personal data, protected by EU privacy regulations. Maybe rector Zauli is confused at to where the Latin-derived word “publications” comes from. It’s from “public” and certainly not from “pubic”, hence definitely not his sphere of personal privacy. Though his publications could profit from some data integrity hygiene. In any case, the Ethics Commission of University of Ferrara will convene on June 1st to decide what to do about the publicly available PubPeer evidence I reported about. The scanned original is here. Please disseminate widely. Continue reading “Zauli and University of Ferrara announce libel suit, criminal prosecution against me”
Cardiff University is very proud of its collaboration with manufacturer of Traditional Chinese Medicine Yiling Pharmaceuticals, while the money it brings in is largely a private issue between the two business partners. Unfortunately Cardiff’s surgery and tumour biology professor Wen Jiang, Fellow of Royal Society of Medicine, is at the centre of an affair about data manipulation in his papers, and about criticisms of peddling Yiling’s TCM concoction of ginseng, dried fungus, chicken gizzard and crushed cockroach as a Cardiff University-certified cancer cure, all involuntarily sponsored by the Welsh public and charity Cancer Research Wales. This is why the university threw their own damning internal investigative report out of the window, and had three poorly qualified experts declare Jiang innocent of any data manipulation in his cell biology papers. Cardiff University issued then a press release accusing me personally of having slandered Jiang with false allegations of misconduct.
After having mulled another one of my Freedom of Information (FOI) inquiries for a month, this time a request for the investigative report, Cardiff University declared that their whitewashing opus is secret, because:
“the formal investigation has not upheld the allegations of misconduct and to further distribute this report would be an unnecessary invasion of the privacy of the individual involved”.
Continue reading “Cardiff: no misconduct by TCM professor Wen Jiang, report secret”
Sonia Melo is back, and not to be messed with. The Portuguese zombie scientist is responsible for a number of papers with manipulated data (only one was retracted, Melo et al, Nature Genetics, 2009), saw her EMBO Young Investigator funding withdrawn in 2016, but was whitewashed and reinstalled by her employing institute Instituto de Investigação e Inovação em Saúde (I3S) in Porto. Her key publication in Nature with MD Anderson professor Raghu Kalluri, Melo et al, 2015, which raised obscene money in industrial and public investment for Kalluri’s spin-off Codyak Biosciences to market exosome-based liquid biopsy for pancreatic cancer detection, was disproven as an artefact at best, the authors even admitted in a follow-up preprint to have intentionally manipulated flow cytometry data to achieve results they needed. Collaborators were instructed never to work with her again. All in all, Melo is as toxic as a zombie scientist can be. But apparently not in her home country Portugal.
In March 2018, Melo received a Prémio FAZ Ciência award from Fundação AstraZeneca (FAZ) and Sociedade Portuguesa de Oncologia (Portuguese Society of Oncology, SPO). Which means, not just Portuguese academia, also international Big Pharma industry trusts her Photoshop skills. The award comes with €35k cash, and this is how much or how little was needed for the University of Porto to drop all pretence at research integrity and celebrate their zombie scientist as a genius researcher about to cure cancer. Continue reading “Zombie scientist Sonia Melo awarded by AstraZeneca”
News from the trachea transplant entrepreneurs. What with the UK authorities having officially suspended both phase 1 clinical trials Inspire and RegenVox, and the EU phase 2 clinical trial TETRA going nowhere, the technology’s owner, Liverpool-based company Videregen decided to seek new clinical partners. Surgeons and universities from outside the EU, especially from US, China and Japan are invited to test Videregen’s trachea transplant technology, which was originally developed together with Paolo Macchiarini by the UCL laryngologist and paid Videregen advisor Martin Birchall.
While tracheal stenosis was the indication sought to treat with trachea transplants in UK and EU (as the authorities drew curtains before the show even started), Videregen now goes for bronchopleural fistula, while pretending (quite dishonestly) that “all required regulatory and ethical approvals necessary to commence clinical trials in the UK” would exist.
The other bit of news is that UCL finally published the 2015 PhD thesis of Birchall’s student Claire Crowley (now postdoctoral scientist in charge of clinical research on oesophagus replacement with UCL professor and another trachea transplanter Paolo De Coppi). It reads as if certain parts of the thesis were edited or even written by UCL’s legal department. Not what thesis says, but what is omitted is worrisome. Crowley was namely responsible for the production of 3 trachea replacements requested by Birchall, which all proved deadly to their human recipients. One was a decellurised cadaveric graft, and two were POSS-PCU plastic tracheas, which Crowley made herself, in the lab of her other advisor, the (now sacked) UCL nanotechnologist Alexander Seifalian. Yet the thesis only mentions one graft, in a brief one-page statement, simply because Crowley could not deny her role there. She is co-author on the Macchiarini paper Jungebluth et al Lancet 2011 telling the alleged success story of the very first plastic trachea transplant performed in Sweden on the patient Andemariam Beyene. Otherwise, Crowley never mentions in her thesis the cases of Keziah Shorten or Shauna Davison, whose lethal trachea grafts she also made herself, as part of her PhD studies. Continue reading “Trachea transplanters without borders”
Gandalf the Wizard has been awarded €75k in cash and Pezcoller-AACR International Award for Extraordinary Achievement in Cancer Research, for his magical western blots, where gel bands multiply under his spell to summon a bigger impact factor. Well, maybe not that Gandalf, but the bearded gel wizard Tony Hunter, of prestigious Salk Institute for Biological Studies (where impure womenfolk is not welcome) in San Diego, California, USA. On April 15th, Hunter will be giving a lecture at the annual meeting of American Association for Cancer Research (AACR) in Chicago, and then go to beautiful Trento in Italy to pick up his award. All because of those western blots of his, which repetitive enchanted beauty was spotted by the image integrity sleuth Clare Francis and then posted on PubPeer. It was in fact Clare Francis who wrote to me to accuse Tony Hunter of being Gandalf The Wizard.
A breathlessly sycophantic article in San Diego Union Tribune described Hunter as “superstar” of 50 years productivity, congratulated him on his new Nature paper and the cash prize, for which the Salk Gandalf can probably buy himself a new BMW broom stick to whiz about, to and fro. That sum of €75k is actually poppycock compared to the $ half a million Tony the Wizard got from the Royal Swedish Academy of Sciences as Sjöberg Prize for Cancer Research, but that is probably intended as lab investment into more of his magic western blots. Probably as compensation for 2012, when Thomson Reuters, (past keepers of the sacred Impact Factor) requested for Gandalf The Western Blot Wizard the Nobel Prize.
So now, let us see what dashing sorcery the King of Sweden and AACR thought was so astounding to give awards for.
Continue reading “Salk Gandalf Tony Hunter gets AACR prize for magic western blots”